Pharmigene

Pharmigene EBIT per Share

The EBIT per Share of Pharmigene (7595.TWO) as of Oct 13, 2026 is -1.12 TWD. In the previous year, EBIT per Share was -1.61 TWD — a change of -30.37% (higher).

EBIT per Share

-1.12TWD

YoY

-30.37%

Last updated:

EBIT per Share of Pharmigene is 2025 -1.12 TWD. EBIT per Share of Pharmigene was 2024 -1.61 TWD. It decreases by -30.37% higher compared to the previous year.

The Pharmigene EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2018
-0.58 TWD
Jan 1, 2019
-1.40 TWD
Jan 1, 2020
-0.42 TWD
Jan 1, 2021
-0.52 TWD
Jan 1, 2022
-1.02 TWD
Jan 1, 2023
-1.25 TWD
Jan 1, 2024
-1.61 TWD
Jan 1, 2025
-1.12 TWD
The Pharmigene EBIT per Share history
YEAREBIT per ShareYoY
-1.12TWD-30.37%
-1.61TWD+29.24%
-1.25TWD+21.85%
-1.02TWD+95.52%
-0.52TWD+25.64%
-0.42TWD-70.19%
-1.40TWD+142.62%
-0.58TWD+32.13%
-0.44TWD—
Access this data via the Eulerpool API
Get Free API Key

Pharmigene Stock analysis

What does Pharmigene do? Pharmigene is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pharmigene stock

EBIT per Share of Pharmigene is -1.12 TWD in 2025.

EBIT per Share of Pharmigene changed from -1.61 TWD to -1.12 TWD, representing a -30.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Pharmigene since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Pharmigene

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Pharmigene